Literature DB >> 21440844

How does cellular heparan sulfate function in viral pathogenicity?

Wuyang Zhu1, Jiangjiao Li, Guodong Liang.   

Abstract

Heparan sulfate (HS) is ubiquitously expressed on the surfaces and in the extracellular matrix of virtually all cell types, making it an ideal receptor for viral infection. Compared with wild-type viruses, cell culture-adapted laboratory strains exhibit more efficient binding to cellular HS receptors. HS-binding viruses are typically cleared faster from the circulation and cause lower viremia than their non-HS-binding counterparts, suggesting that the HS-binding phenotype is a tissue culture adaptation that lowers virus fitness in vivo. However, when inoculated intracranially, efficient cell attachment through HS binding can contribute to viral neurovirulence. The primary aim of this review is to discuss the roles of HS binding in viral pathogenicity, including peripheral virulence and neurovirulence. Understanding how heparan sulfate functions during virus infection in vivo may prove critical for elucidating the molecular mechanism of viral pathogenesis, and may contribute to the development of therapeutics targeting HS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440844     DOI: 10.3967/0895-3988.2011.01.011

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  21 in total

Review 1.  Whole-genome sequencing in outbreak analysis.

Authors:  Carol A Gilchrist; Stephen D Turner; Margaret F Riley; William A Petri; Erik L Hewlett
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

2.  Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses.

Authors:  Jennifer P Wang; Robert W Finberg; Gabriel L Hendricks; Lourdes Velazquez; Serena Pham; Natasha Qaisar; James C Delaney; Karthik Viswanathan; Leila Albers; James C Comolli; Zachary Shriver; David M Knipe; Evelyn A Kurt-Jones; Deborah K Fygenson; Jose M Trevejo
Journal:  Antiviral Res       Date:  2015-01-28       Impact factor: 5.970

3.  Mass spectrometric method for determining the uronic acid epimerization in heparan sulfate disaccharides generated using nitrous acid.

Authors:  Vanessa Leah Gill; Qi Wang; Xiaofeng Shi; Joseph Zaia
Journal:  Anal Chem       Date:  2012-08-20       Impact factor: 6.986

4.  Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate.

Authors:  Andres Chang; Cyril Masante; Ursula J Buchholz; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

5.  Initial evidence on differences among Enterovirus 71, Coxsackievirus A16 and Coxsackievirus B4 in binding to cell surface heparan sulphate.

Authors:  Hamid Reza Pourianfar; Kristin Kirk; Lara Grollo
Journal:  Virusdisease       Date:  2013-12-04

6.  DC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.

Authors:  Leah Gillespie; Kathleen Gerstenberg; Fernanda Ana-Sosa-Batiz; Matthew S Parsons; Rubaiyea Farrukee; Mark Krabbe; Kirsten Spann; Andrew G Brooks; Sarah L Londrigan; Patrick C Reading
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

7.  Virus entry. Lassa virus entry requires a trigger-induced receptor switch.

Authors:  Lucas T Jae; Matthijs Raaben; Andrew S Herbert; Ana I Kuehne; Ariel S Wirchnianski; Timothy K Soh; Sarah H Stubbs; Hans Janssen; Markus Damme; Paul Saftig; Sean P Whelan; John M Dye; Thijn R Brummelkamp
Journal:  Science       Date:  2014-06-27       Impact factor: 47.728

8.  Exploitation of Cellular Cytoskeletons and Signaling Pathways for Cell Entry by Kaposi's Sarcoma-Associated Herpesvirus and the Closely Related Rhesus Rhadinovirus.

Authors:  Wei Zhang; Shou-Jiang Gao
Journal:  Pathogens       Date:  2012-10-22

Review 9.  Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream.

Authors:  Stephanie E Ander; Frances S Li; Kathryn S Carpentier; Thomas E Morrison
Journal:  PLoS Pathog       Date:  2022-05-05       Impact factor: 7.464

10.  Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2.

Authors:  Ma'ayan Israeli; Yaara Finkel; Yfat Yahalom-Ronen; Nir Paran; Theodor Chitlaru; Ofir Israeli; Inbar Cohen-Gihon; Moshe Aftalion; Reut Falach; Shahar Rotem; Uri Elia; Ital Nemet; Limor Kliker; Michal Mandelboim; Adi Beth-Din; Tomer Israely; Ofer Cohen; Noam Stern-Ginossar; Adi Bercovich-Kinori
Journal:  Nat Commun       Date:  2022-04-25       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.